Clinical Trial Update: CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (CCCG-ALCL-2020) in Chinese children and adolescents with newly diagnosed high-risk anaplastic large cell lymphoma is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma

Snippet

Sponsor: Children's Cancer Group, China | Conditions: Pediatric Anaplastic Large Cell Lymphoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING